Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies
TOKYO, Apr 23, 2021 – (JCN Newswire via SEAPRWire.com) – Gilead Sciences K.K. and Eisai Co., Ltd. today announced that Gilead submitted an application to Japan’s Pharmaceuticals and Medical Devices […]